What Is Neuronox? Results, Duration & Side Effects What Is Neuronox? Results, Duration & Side Effects


If You Need to Improve These


Frown lines

Frown lines

Forehead lines

Forehead lines

Crow's feet

Crow's feet

Looking stern

Looking stern


CHECK IT!
Neuronox Cases
Before & After
Neuronox case: forehead lines, before
Before Forehead Lines
Neuronox case: forehead lines, after
After

*Cases reflect individual experiences; treatment areas, dosage and photo intervals vary, and results differ from person to person.

Neuronox
Am I a Candidate?

Moderate to severe frown lines-ICON

Moderate to severe
frown lines

Forehead lines, crow's feet and other dynamic lines (physician assessed)-ICON

Forehead lines, crow's feet
(physician assessed)

Wanting a more relaxed, softer expression-ICON

A more relaxed,
softer expression

Other areas, assessed by a physician-ICON

Other areas,
assessed by a physician

What is Neuronox?

Appearance of Neuronox Product

Neuronox® (Miracle Botox), developed by Korean biopharmaceutical company Medytox, was approved in Korea in 2006, making it the first botulinum toxin type A developed in Korea to be approved for market. Based on its approved indications and your needs, a physician can assess its use for concerns such as dynamic wrinkles.

Botulinum toxin is a purified neurotoxin protein produced by Clostridium botulinum. It works mainly by inhibiting the release of acetylcholine from nerve endings, temporarily reducing contraction of the target muscles. There are seven serotypes, A to G, and type A is the one most commonly used in clinical and aesthetic medicine. Neuronox uses botulinum toxin type A for muscle-relaxing treatments; actual results and duration vary with the treatment area, dose and individual factors.

Neuronox 4 Key Features

  1. Quality-managed by the Korean manufacturer: A botulinum toxin type A developed and manufactured by Medytox under pharmaceutical manufacturing and quality management regulations.-ICON
    Quality-managed by the Korean manufacturer: A botulinum toxin type A developed and manufactured by Medytox under pharmaceutical manufacturing and quality management regulations.
  2. Supported by clinical studies: Neuronox has clinical study data for indications such as glabellar lines; actual efficacy and safety should be assessed according to approved indications, product labeling and individual conditions.-ICON
    Supported by clinical studies: Neuronox has clinical study data for indications such as glabellar lines; actual efficacy and safety should be assessed according to approved indications, product labeling and individual conditions.
  3. Multiple vial sizes: Available in 100U and 200U vials, so physicians can plan an appropriate dose for approved uses and individual needs.-ICON
    Multiple vial sizes: Available in 100U and 200U vials, so physicians can plan an appropriate dose for approved uses and individual needs.
  4. Clinical experience among Korean physicians: In a survey of Korean dermatologists published in Toxins in 2022, Meditoxin/Neuronox was the botulinum toxin most commonly used by respondents (62.3%).-ICON
    Clinical experience among Korean physicians: In a survey of Korean dermatologists published in Toxins in 2022, Meditoxin/Neuronox was the botulinum toxin most commonly used by respondents (62.3%).

Neuronox
Treatment Area Assessment

Treatment area assessment diagram: Forehead lines, frown lines, bunny lines, smile lines, crow's feet, upper face lift, masseter muscle, jawline lift, trapezius, platysma, underarms, calf muscles

*Under its approved indication in Taiwan, Neuronox may be used for the temporary improvement of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity. Other areas shown are not approved indications in Taiwan; suitability must be assessed by a physician.

ATTENTION
Neuronox Precautions

1

Avoid injections if allergic to botulinum toxin.

2

Not recommended for pregnant or breastfeeding women.

3

Inform your physician beforehand if you have a neuromuscular disorder such as myasthenia gravis or Lambert-Eaton syndrome, or take medications that may affect neuromuscular transmission.

4

Avoid rubbing or massaging the treated area after injection; follow your physician's instructions for other aftercare.

5

Avoid high temperatures such as sun exposure, saunas, and ovens within a week.

6

Soreness, redness, swelling, bruising or headache may occur at the injection site and usually subside gradually, though severity and duration vary. In rare cases, eyelid drooping or localized muscle weakness may occur; seek medical care immediately if you have difficulty swallowing, breathing or speaking.

FAQ
About Neuronox

Results usually appear gradually over several days, and your physician can assess your response at about 1-2 weeks. When results begin and reach their full effect varies with individual factors, dose and treatment area.

Botulinum toxin effects are not permanent. Results for glabellar lines usually last several months, about 3-4 months for some patients, and vary with muscle activity, dose and individual response.

Pain, redness, swelling, bruising, headache or muscle weakness may occur at the injection site, and some patients may experience eyelid drooping. Seek medical care immediately if you have difficulty swallowing, breathing or speaking, or generalized muscle weakness.

The timing of repeat injections should be decided by your physician based on your previous results and how muscle activity has recovered. Avoid requesting frequent touch-ups within a short period to reduce unnecessary risks.

Under its approved indication in Taiwan, Neuronox may be used for the temporary improvement of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity. Whether other areas are suitable must be assessed by a physician.